Article
Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
PloS one - 4 Nov 2009
Kotoula Vassiliki, Charalambous Elpida, Biesmans Bart, Malousi Andigoni, Vrettou Eleni, Fountzilas George, Karkavelas George
Abstract excerpt
BACKGROUND: Testing for tumor specific mutations on routine formalin-fixed paraffin-embedded (FFPE) tissues may predict response to treatment in Medical Oncology and has already entered diagnostics, with KRAS mutation assessment as a paradigm. The highly sensitive real time PCR (Q-PCR) methods developed for this purpose are usually standardized under optimal template conditions. In routine diagnostics, however,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
